FDA Approves First GLP-1 Pill for Weight Loss
In a significant health development, the FDA has approved the first GLP-1 tablet aimed at assisting with weight loss. This new oral option is poised to offer an alternative to the injection-based GLP-1 treatments currently available.
GLP-1 medications have become highly popular for weight loss this year, but some older adults are reportedly moving away from these treatments. A recent study published in JAMA showed that nearly 47% of individuals with type 2 diabetes and 65% of those without diabetes had stopped taking their prescribed GLP-1 medications within a year of starting.
According to Dr. John Batsis, an expert in geriatrics and obesity from the University of North Carolina, older individuals, especially those over 65, are key candidates for these therapies, as the obesity rate in this age group is around 40%.
GLP-1 drugs work by mimicking a natural hormone that helps control appetite and manage blood sugar levels. Besides assisting with weight loss, these medications have also been investigated for treating sleep apnea and other heart-related issues.
Despite their effectiveness, many older adults have been discontinuing these drugs for several reasons, including side effects and rising costs. Here’s a closer look at why some seniors may not continue their GLP-1 prescriptions:
1. Cost
The expense of GLP-1 medications, like Ozempic, plays a major role in sticking with treatment. Mary Bucklew, a 75-year-old retiree from Delaware, shared her story of losing 25 pounds while on Ozempic, but when her insurance stopped covering the medication, her monthly out-of-pocket cost soared to over $1,000, forcing her to stop treatment.
While some companies are working to make their products more affordable, significant barriers still exist for many individuals seeking these treatments.
2. Side Effects
Side effects are another key reason seniors stop taking GLP-1 medications. Dr. Sue Decotiis, a medical weight loss doctor, noted that common issues such as nausea, vomiting, diarrhea, and fatigue often lead to discontinuation. Older patients might be more prone to these gastrointestinal side effects, requiring careful medical oversight.
3. Dehydration
Another challenge for seniors is dehydration. Many older adults already struggle with hydration, and GLP-1 side effects can exacerbate this issue. Doctors emphasize the importance of staying hydrated, particularly for patients with kidney concerns.
4. Muscle Loss
Finally, muscle loss is a significant side effect of GLP-1 medications that can be problematic for older adults. Loss of muscle mass, which naturally occurs with age, can heighten the risk of falls and injuries. Experts recommend monitoring muscle mass closely for seniors on these medications.
The combination of these factors has led to a growing trend of older adults discontinuing their GLP-1 medications. Experts stress the importance of personalized care and regular monitoring to help patients adhere to their treatments successfully.
Conclusion
Finding success with GLP-1 medications can often depend on the level of personalized care patients receive. Healthcare providers who closely monitor their patients can help them navigate side effects and maintain their weight loss efforts effectively.
